Unibest
← Back to patent-cliff list

Sinapultide

Tier C — Watch / trade

Sinapultide

The Scripps Research Institute Inc
Originator
2012
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type

Targets:Not applicable

Brand:Surfaxin LS, Surfaxin, AEROSURF

Indications (approved):Acute respiratory distress syndrome, COVID-19, 新生儿呼吸窘迫综合征

Regional status

US
Phase II
2021-01-05
EU
Discontinued
2020-04-18
China
-
Japan
-

Synthetic routes & intermediates1 routes

Originator routes × 1Optimised (non-patent) × 0Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 10 · Total yield 0.4 g
SINA-00135661-60-0SINA-002—SINA-003—SINA-004—SINA-005—SINA-00671989-26-9SINA-007—SINA-0081417727-85-5SINA-009—SINA-010—SINA-011—SINA-012—API · Sinapultide
CodeCAS No.Intermediate
SINA-00135661-60-0(((9H-fluoren-9-yl)methoxy)carbonyl)-L-leucine
SINA-002-methyl (((9H-fluoren-9-yl)methoxy)carbonyl)-L-leucinate
SINA-003-methyl (((9H-fluoren-9-yl)methoxy)carbonyl)-L-leucyl-L-leucinate
SINA-004-methyl (((9H-fluoren-9-yl)methoxy)carbonyl)-L-leucyl-L-leucyl-L-leucinate
SINA-005-methyl (((9H-fluoren-9-yl)methoxy)carbonyl)-L-leucyl-L-leucyl-L-leucyl-L-leucinate
SINA-00671989-26-9(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-6-((tert-butoxycarbonyl)amino)hexanoic acid
SINA-007-methyl N2-(((9H-fluoren-9-yl)methoxy)carbonyl)-N6-(tert-butoxycarbonyl)-L-lysyl-L-leucyl-L-leucyl-L-leucyl-L-leucinate
SINA-0081417727-85-5N2-(((9H-fluoren-9-yl)methoxy)carbonyl)-N6-(tert-butoxycarbonyl)-L-lysyl-L-leucyl-L-leucyl-L-leucyl-L-leucine
SINA-009-methyl N6-(tert-butoxycarbonyl)-N2-N6-(tert-butoxycarbonyl)-L-lysyl-L-leucyl-L-leucyl-L-leucyl-L-leucyl-L-lysinate
SINA-010-methyl N6-(tert-butoxycarbonyl)-N2-N6-(tert-butoxycarbonyl)-N2-N6-(tert-butoxycarbonyl)-L-lysyl-L-leucyl-L-leucyl-L-leucyl-L-leucyl-L-lysyl-L-leucyl-L-leucyl-L-leucyl-L-leucyl-L-lysinate
SINA-011--
SINA-012--

Frequently asked questions

What are the approved indications of Sinapultide?

Approved indications include: Acute respiratory distress syndrome, COVID-19, 新生儿呼吸窘迫综合征.

When does the Sinapultide patent expire?

No public expiry year is available for Sinapultide yet; this page updates once verified.

How many synthesis routes are recorded for Sinapultide?

1 synthesis routes are recorded; the shortest is 10 steps with 0.4 g total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Sinapultide intermediates?

All intermediates in Sinapultide routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.

How do I get a quote for Sinapultide intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-10-07